CIK 0001799788
- Non-accelerated filer
- Smaller reporting company
Greenwich LifeSciences, Inc.
Sign in to watch- Ticker
- GLSI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 205473709
- Phone
- +1 203-434-3290
- Business address
- 3992 BLUEBONNET DR, BUILDING 14, STAFFORD, TX, 77477
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-11 | Patel Snehal CEO and CFO | Purchase | +5,000 | $12.42 | $62K | 5,271,177 |
| 2023-03-15 | Thompson Jaye VP Clinical Reg Affairs | Purchase | +250 | $12.71 | $3K | 257,745 |
| 2023-03-10 | Patel Snehal CEO and CFO | Purchase | +1,000 | $12.12 | $12K | 2,737,486 |
| 2023-02-24 | Thompson Jaye VP Clinical Reg Affairs | Purchase | +250 | $15.40 | $4K | 257,495 |
| 2023-02-17 | Patel Snehal CEO and CFO | Purchase | +600 | $16.53 | $10K | 2,736,486 |
| 2023-02-10 | Patel Snehal CEO and CFO | Purchase | +1,000 | $18.68 | $19K | 2,735,886 |
| 2023-02-03 | Thompson Jaye VP Clinical Reg Affairs | Purchase | +250 | $20.84 | $5K | 257,245 |
| 2023-01-27 | Patel Snehal CEO and CFO | Purchase | +2,000 | $19.35 | $39K | 2,734,886 |
| 2023-01-27 | Thompson Jaye VP Clinical Reg Affairs | Purchase | +250 | $19.20 | $5K | 256,995 |
| 2023-01-20 | Patel Snehal CEO and CFO | Purchase | +1,500 | $17.37 | $26K | 2,732,886 |
| 2023-01-13 | Thompson Jaye VP Clinical Reg Affairs | Purchase | +250 | $16.50 | $4K | 256,745 |
| 2023-01-06 | Patel Snehal CEO and CFO | Purchase | +1,500 | $15.18 | $23K | 2,731,386 |
| 2022-12-29 | Patel Snehal CEO and CFO | Purchase | +4,000 | $15.19 | $61K | 2,729,886 |
| 2022-12-16 | Patel Snehal CEO and CFO | Purchase | +1,000 | $13.01 | $13K | 2,725,886 |
| 2022-12-16 | Thompson Jaye VP Clinical Reg Affairs | Purchase | +250 | $12.94 | $3K | 256,495 |
| 2022-12-09 | Patel Snehal CEO and CFO | Purchase | +2,000 | $13.11 | $26K | 2,724,886 |
| 2022-12-02 | Patel Snehal CEO and CFO | Purchase | +1,000 | $13.84 | $14K | 2,722,886 |
| 2022-12-02 | Thompson Jaye VP Clinical Reg Affairs | Purchase | +250 | $13.98 | $3K | 256,245 |
| 2022-11-02 | Patel Snehal CEO and CFO | Purchase | +2,000 | $8.79 | $18K | 2,721,886 |
| 2022-10-14 | Patel Snehal CEO and CFO | Purchase | +3,000 | $9.75 | $29K | 2,719,886 |
Page 4 of 7 · 122 trades